Alpha-synuclein oligomerization and dopaminergic degeneration occur synchronously in the brain and colon of MPTP-intoxicated parkinsonian monkeys

•α-Syn oligomerization occurs in parallel in the brain and colon of MPTP-treated monkeys.•α-Syn oligomerization correlates with its phosphorylation in MPTP-treated monkeys.•α-Syn phosphorylation is accompanied by alterations in its regulatory enzymes PP2A and PLK2.•DAergic degeneration is synchroniz...

Full description

Saved in:
Bibliographic Details
Published inNeuroscience letters Vol. 716; p. 134640
Main Authors Li, Xuran, Yang, Weiwei, Li, Xin, Chen, Min, Liu, Chengwei, Li, Jie, Yu, Shun
Format Journal Article
LanguageEnglish
Published Ireland Elsevier B.V 18.01.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract •α-Syn oligomerization occurs in parallel in the brain and colon of MPTP-treated monkeys.•α-Syn oligomerization correlates with its phosphorylation in MPTP-treated monkeys.•α-Syn phosphorylation is accompanied by alterations in its regulatory enzymes PP2A and PLK2.•DAergic degeneration is synchronized in the brain and colon of MPTP-treated monkeys.•Altered PLK2 and PP2A activity contribute to α-syn phosphorylation and oligomerization. Dopaminergic (DAergic) degeneration and abnormal α-synuclein (α-syn) expression, phosphorylation and aggregation are observed in both the nigrostriatal system (NSS) and enteric nervous system (ENS) of patients with Parkinson’s disease (PD). Whether these alterations in α-syn and DAergic neurons occur synchronously in the two nervous systems or follow a process that spreads from the gut to the brain remains a subject of debate. Here, in MPTP-intoxicated cynomolgus monkeys, we showed a parallel DAergic degeneration in the colon as well as in the substantia nigra and striatum (SN/STR), as indicated by reduced expression of tyrosine hydroxylase (TH) and dopamine transporter (DAT). In addition, we observed a simultaneous increase in the concentrations of total, phosphorylated, and oligomeric α-syn in the colon and SN/STR. Moreover, we identified that the above changes in α-syn were associated with an increase in the expression of polo-like kinase 2 (PLK2), an enzyme that promotes α-syn phosphorylation, and a decrease in the activity of protein phosphatase 2A (PP2A), an enzyme that facilitates α-syn dephosphorylation. Because the colonic ENS can be readily analyzed using routine biopsies, the shared pathological features between the colonic ENS and the brain NSS found in this study provide useful information for assessing and understanding the neuropathology in PD patients using colonic biopsies.
AbstractList Dopaminergic (DAergic) degeneration and abnormal α-synuclein (α-syn) expression, phosphorylation and aggregation are observed in both the nigrostriatal system (NSS) and enteric nervous system (ENS) of patients with Parkinson's disease (PD). Whether these alterations in α-syn and DAergic neurons occur synchronously in the two nervous systems or follow a process that spreads from the gut to the brain remains a subject of debate. Here, in MPTP-intoxicated cynomolgus monkeys, we showed a parallel DAergic degeneration in the colon as well as in the substantia nigra and striatum (SN/STR), as indicated by reduced expression of tyrosine hydroxylase (TH) and dopamine transporter (DAT). In addition, we observed a simultaneous increase in the concentrations of total, phosphorylated, and oligomeric α-syn in the colon and SN/STR. Moreover, we identified that the above changes in α-syn were associated with an increase in the expression of polo-like kinase 2 (PLK2), an enzyme that promotes α-syn phosphorylation, and a decrease in the activity of protein phosphatase 2A (PP2A), an enzyme that facilitates α-syn dephosphorylation. Because the colonic ENS can be readily analyzed using routine biopsies, the shared pathological features between the colonic ENS and the brain NSS found in this study provide useful information for assessing and understanding the neuropathology in PD patients using colonic biopsies.
Dopaminergic (DAergic) degeneration and abnormal α-synuclein (α-syn) expression, phosphorylation and aggregation are observed in both the nigrostriatal system (NSS) and enteric nervous system (ENS) of patients with Parkinson's disease (PD). Whether these alterations in α-syn and DAergic neurons occur synchronously in the two nervous systems or follow a process that spreads from the gut to the brain remains a subject of debate. Here, in MPTP-intoxicated cynomolgus monkeys, we showed a parallel DAergic degeneration in the colon as well as in the substantia nigra and striatum (SN/STR), as indicated by reduced expression of tyrosine hydroxylase (TH) and dopamine transporter (DAT). In addition, we observed a simultaneous increase in the concentrations of total, phosphorylated, and oligomeric α-syn in the colon and SN/STR. Moreover, we identified that the above changes in α-syn were associated with an increase in the expression of polo-like kinase 2 (PLK2), an enzyme that promotes α-syn phosphorylation, and a decrease in the activity of protein phosphatase 2A (PP2A), an enzyme that facilitates α-syn dephosphorylation. Because the colonic ENS can be readily analyzed using routine biopsies, the shared pathological features between the colonic ENS and the brain NSS found in this study provide useful information for assessing and understanding the neuropathology in PD patients using colonic biopsies.Dopaminergic (DAergic) degeneration and abnormal α-synuclein (α-syn) expression, phosphorylation and aggregation are observed in both the nigrostriatal system (NSS) and enteric nervous system (ENS) of patients with Parkinson's disease (PD). Whether these alterations in α-syn and DAergic neurons occur synchronously in the two nervous systems or follow a process that spreads from the gut to the brain remains a subject of debate. Here, in MPTP-intoxicated cynomolgus monkeys, we showed a parallel DAergic degeneration in the colon as well as in the substantia nigra and striatum (SN/STR), as indicated by reduced expression of tyrosine hydroxylase (TH) and dopamine transporter (DAT). In addition, we observed a simultaneous increase in the concentrations of total, phosphorylated, and oligomeric α-syn in the colon and SN/STR. Moreover, we identified that the above changes in α-syn were associated with an increase in the expression of polo-like kinase 2 (PLK2), an enzyme that promotes α-syn phosphorylation, and a decrease in the activity of protein phosphatase 2A (PP2A), an enzyme that facilitates α-syn dephosphorylation. Because the colonic ENS can be readily analyzed using routine biopsies, the shared pathological features between the colonic ENS and the brain NSS found in this study provide useful information for assessing and understanding the neuropathology in PD patients using colonic biopsies.
•α-Syn oligomerization occurs in parallel in the brain and colon of MPTP-treated monkeys.•α-Syn oligomerization correlates with its phosphorylation in MPTP-treated monkeys.•α-Syn phosphorylation is accompanied by alterations in its regulatory enzymes PP2A and PLK2.•DAergic degeneration is synchronized in the brain and colon of MPTP-treated monkeys.•Altered PLK2 and PP2A activity contribute to α-syn phosphorylation and oligomerization. Dopaminergic (DAergic) degeneration and abnormal α-synuclein (α-syn) expression, phosphorylation and aggregation are observed in both the nigrostriatal system (NSS) and enteric nervous system (ENS) of patients with Parkinson’s disease (PD). Whether these alterations in α-syn and DAergic neurons occur synchronously in the two nervous systems or follow a process that spreads from the gut to the brain remains a subject of debate. Here, in MPTP-intoxicated cynomolgus monkeys, we showed a parallel DAergic degeneration in the colon as well as in the substantia nigra and striatum (SN/STR), as indicated by reduced expression of tyrosine hydroxylase (TH) and dopamine transporter (DAT). In addition, we observed a simultaneous increase in the concentrations of total, phosphorylated, and oligomeric α-syn in the colon and SN/STR. Moreover, we identified that the above changes in α-syn were associated with an increase in the expression of polo-like kinase 2 (PLK2), an enzyme that promotes α-syn phosphorylation, and a decrease in the activity of protein phosphatase 2A (PP2A), an enzyme that facilitates α-syn dephosphorylation. Because the colonic ENS can be readily analyzed using routine biopsies, the shared pathological features between the colonic ENS and the brain NSS found in this study provide useful information for assessing and understanding the neuropathology in PD patients using colonic biopsies.
ArticleNumber 134640
Author Yang, Weiwei
Li, Jie
Li, Xuran
Chen, Min
Liu, Chengwei
Li, Xin
Yu, Shun
Author_xml – sequence: 1
  givenname: Xuran
  surname: Li
  fullname: Li, Xuran
  organization: Department of Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, China
– sequence: 2
  givenname: Weiwei
  surname: Yang
  fullname: Yang, Weiwei
  organization: Department of Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, China
– sequence: 3
  givenname: Xin
  surname: Li
  fullname: Li, Xin
  organization: Department of Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, China
– sequence: 4
  givenname: Min
  surname: Chen
  fullname: Chen, Min
  organization: Laboratory of Neuroscience, Affiliated Hospital of Guilin Medical University, Guilin, China
– sequence: 5
  givenname: Chengwei
  surname: Liu
  fullname: Liu, Chengwei
  organization: Laboratory of Neuroscience, Affiliated Hospital of Guilin Medical University, Guilin, China
– sequence: 6
  givenname: Jie
  surname: Li
  fullname: Li, Jie
  organization: Department of Neurology, Beijing Daxing District Hospital of Integrated Traditional Chinese and Western Medicine, Beijing, China
– sequence: 7
  givenname: Shun
  surname: Yu
  fullname: Yu, Shun
  email: yushun103@163.com
  organization: Department of Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31759083$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1u1DAUhS1URKeFN0DISzYZ7NjODwukquJPKqKLsrac6zszniZ2sJ2K4S36xs2QwoIFrGzJ3zmSv3NGTnzwSMhLztac8erNfu1x6jGvS8bbNReykuwJWfGmLou6rcsTsmKCyUK0kp2Ss5T2jDHFlXxGTgWvVcsasSL3F_24M0U6-Al6dJ6G3m3DgNH9NNkFT4231IbRDM5j3DqgFrc4X5fXADBFOqdhF4MPU-oPdC7JO6RdNG6JQ-iP6IZ-ub65LpzP4YcDk9HS0cRb51Pwzng6BH-Lh_ScPN2YPuGLx_OcfPvw_ubyU3H19ePny4urAkRV5gK6qhRooTSsrQTvlAQmRcWNmT1YUQvWKrCmahSoToEQYNFg18AGgaFR4py8XnrHGL5PmLIeXALse-Nx_oguj5KaWkk5o68e0akb0OoxusHEg_6tcQbkAkAMKUXc_EE408e19F4va-njWnpZa469_SsGLv8Sm2d5_f_C75YwzpLuHEadwKEHtC4iZG2D-3fBA03JtxE
CitedBy_id crossref_primary_10_3389_fonc_2022_956225
crossref_primary_10_1152_jn_00106_2024
crossref_primary_10_34133_research_0183
crossref_primary_10_1080_15548627_2024_2448914
crossref_primary_10_2174_1874196702008010006
crossref_primary_10_3390_brainsci12060779
crossref_primary_10_3390_ijms23158586
crossref_primary_10_1016_j_ejphar_2022_175029
crossref_primary_10_3390_molecules27217414
crossref_primary_10_3390_biomedicines12081634
crossref_primary_10_3389_fnagi_2024_1437622
crossref_primary_10_1016_j_neurobiolaging_2023_05_007
crossref_primary_10_1007_s11427_020_1756_9
crossref_primary_10_1038_s41531_020_00150_x
crossref_primary_10_3390_biomedicines9030272
crossref_primary_10_1016_j_brainresbull_2021_09_009
crossref_primary_10_3389_fnagi_2022_899892
crossref_primary_10_1007_s00259_024_06638_5
crossref_primary_10_1016_j_brainres_2021_147609
Cites_doi 10.1016/j.neuroscience.2014.12.003
10.3390/ijerph13090881
10.3233/JPD-160779
10.1016/j.bbadis.2008.11.007
10.1016/j.parkreldis.2018.08.010
10.3389/fnana.2014.00083
10.1016/j.nbd.2005.05.028
10.1016/j.neulet.2005.11.012
10.1016/j.expneurol.2008.01.004
10.1002/mds.26480
10.1002/cmdc.201300166
10.1016/j.neuint.2019.03.013
10.1016/j.nbd.2018.01.008
10.5056/jnm17141
10.1073/pnas.0904229106
10.1016/S0306-4522(03)00036-8
10.1016/j.tins.2016.10.008
10.1016/0006-8993(84)90777-7
10.1016/j.neulet.2017.10.047
10.1096/fj.03-1449com
10.1016/j.neuroscience.2018.03.026
10.1016/j.neuroscience.2012.01.028
10.1016/j.pharmthera.2019.02.011
10.1093/jnen/nly024
10.1016/0006-8993(90)91788-I
10.1016/j.neuron.2019.05.035
10.1007/s00415-012-6801-2
10.1093/ilar/ilx021
10.1016/j.neurobiolaging.2015.06.004
10.1016/S0140-6736(14)61393-3
10.1038/cddis.2014.175
10.1016/j.neuroscience.2006.12.028
10.1007/s12264-016-0069-y
10.3233/JAD-2001-3608
10.3389/fnins.2019.00382
10.1097/00001756-200001170-00041
10.18632/oncotarget.6445
10.3390/ijms18020469
10.1016/j.jns.2014.03.028
ContentType Journal Article
Copyright 2019 Elsevier B.V.
Copyright © 2019 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2019 Elsevier B.V.
– notice: Copyright © 2019 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.neulet.2019.134640
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1872-7972
ExternalDocumentID 31759083
10_1016_j_neulet_2019_134640
S0304394019307438
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
-~X
.~1
0R~
123
1B1
1RT
1~.
1~5
4.4
457
4G.
53G
5RE
7-5
71M
8P~
9JM
AABNK
AACTN
AADPK
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAXLA
AAXUO
ABCQJ
ABFNM
ABFRF
ABJNI
ABLJU
ABMAC
ABYKQ
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGWIK
AGYEJ
AIEXJ
AIKHN
AITUG
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
KOM
M2V
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SPCBC
SSN
SSZ
T5K
WH7
YCJ
~G-
.55
.GJ
29N
5VS
AAEDT
AAQFI
AAQXK
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ABXDB
ACRPL
ACVFH
ADCNI
ADIYS
ADMUD
ADNMO
AEIPS
AETEA
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AHHHB
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
ASPBG
AVWKF
AZFZN
BNPGV
CITATION
FEDTE
FGOYB
G-2
HMQ
HVGLF
HZ~
MVM
R2-
SEW
SNS
SSH
WUQ
X7M
ZGI
ZXP
ZY4
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c362t-cb623edc2a09631b54c04361aa640d373095cda685c5b5c33cdeaeb8cfec0ea53
IEDL.DBID .~1
ISSN 0304-3940
1872-7972
IngestDate Fri Jul 11 00:38:55 EDT 2025
Thu Apr 03 07:05:22 EDT 2025
Thu Apr 24 23:00:59 EDT 2025
Tue Jul 01 01:44:00 EDT 2025
Fri Feb 23 02:47:59 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords DAergic
Substantia nigra
CNS
ENS
MPP
STR
m-α
Dopaminergic neurons
p-α-syn
SD
Striatum
PNS
SN
Colon
α-synuclein
PBS
t-α-syn
EGCG
PLK2
PP2A
PVDF
NSS
LNs
SDS-PAGE
PD
TH
α-syn
o-α-syn
DAT
MPTP
LBs
Parkinson’s disease
ELISA
Language English
License Copyright © 2019 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c362t-cb623edc2a09631b54c04361aa640d373095cda685c5b5c33cdeaeb8cfec0ea53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 31759083
PQID 2317587544
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2317587544
pubmed_primary_31759083
crossref_primary_10_1016_j_neulet_2019_134640
crossref_citationtrail_10_1016_j_neulet_2019_134640
elsevier_sciencedirect_doi_10_1016_j_neulet_2019_134640
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-01-18
PublicationDateYYYYMMDD 2020-01-18
PublicationDate_xml – month: 01
  year: 2020
  text: 2020-01-18
  day: 18
PublicationDecade 2020
PublicationPlace Ireland
PublicationPlace_xml – name: Ireland
PublicationTitle Neuroscience letters
PublicationTitleAlternate Neurosci Lett
PublicationYear 2020
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Yue, Zeng, Tang, Tao, Chan (bib0065) 2017; 33
Goetze, Woitalla (bib0180) 2008; 210
Huang, Wu, Wang, Ge, Rizak, Wu, Li, Xu, Lv, Yin, Hu, Li (bib0055) 2018; 379
Liu, Chen, Mi, Yang, Li, Wang, Yin, Li, Yue, Chan, Yu (bib0090) 2015; 36
Wu, Lou, Alerte, Stachowski, Chen, Singleton, Hamilton, Perez (bib0100) 2012; 207
Ruffmann, Parkkinen (bib0115) 2016; 31
Scudamore, Ciossek (bib0130) 2018; 77
Dong, Qin, Huang, Ji, Wu (bib0160) 2019; 126
Engelender, Isacson (bib0185) 2017; 40
Bourdenx, Bezard, Dehay (bib0135) 2014; 8
Chen, Wang, Yue, Li, Wang, Li, Chan, Yu (bib0165) 2015; 286
Manfredsson, Luk, Benskey, Gezer, Garcia, Kuhn, Sandoval, Patterson, O’Mara, Yonkers, Kordower (bib0175) 2018; 112
Cersosimo, Raina, Pecci, Pellene, Calandra, Gutierrez, Micheli, Benarroch (bib0010) 2013; 260
Hinkle, Perepezko, Mills, Mari, Butala, Dawson, Pantelyat, Rosenthal, Pontone (bib0105) 2018; 55
Kim, Kwon, Kam, Panicker, Karuppagounder, Lee, Lee, Kim, Kook, Foss, Shen, Lee, Kulkarni, Pasricha, Lee, Pomper, Dawson, Dawson, Ko (bib0170) 2019; 103
Oueslati (bib0020) 2016; 6
Emborg (bib0030) 2017; 58
Canerina-Amaro, Pereda, Diaz, Rodriguez-Barreto, Casanas-Sanchez, Heffer, Garcia-Esparcia, Ferrer, Puertas-Avendano, Marin (bib0060) 2019; 13
Kalia, Lang (bib0005) 2015; 386
Yu, Li, Liu, Han, Zhang, Li, Xu, Liu, Gao, Yang, Ueda, Chan (bib0085) 2007; 145
Hossain, Alim, Takeda, Kaji, Shinoda, Ueda (bib0070) 2001; 3
Perez-Revuelta, Hettich, Ciociaro, Rotermund, Kahle, Krauss, Di Monte (bib0145) 2014; 5
Kozina, Khakimova, Khaindrava, Kucheryanu, Vorobyeva, Krasnov, Georgieva, Kerkerian-Le Goff, Ugrumov (bib0110) 2014; 340
Lee, Jung, Chung, Hong, Kim, Lee, Hwang, Ryu, Kim, Lee, Seo, Park, Yang, Ye, Byeon, Choe, Jung, Yang, Myung (bib0015) 2018; 24
Chen, Yang, Li, Li, Wang, Yue, Yang, Chan, Yu (bib0095) 2016; 7
El-Agnaf, Salem, Paleologou, Curran, Gibson, Court, Schlossmacher, Allsop (bib0080) 2006; 20
Riachi, Dietrich, Harik (bib0120) 1990; 533
Elgenaidi, Spiers (bib0155) 2019; 198
Purisai, McCormack, Langston, Johnston, Di Monte (bib0035) 2005; 20
Kowall, Hantraye, Brouillet, Beal, McKee, Ferrante (bib0040) 2000; 11
Valdinocci, Radford, Siow, Chung, Pountney (bib0195) 2017; 18
Langston, Forno, Rebert, Irwin (bib0045) 1984; 292
Nandipati, Litvan (bib0190) 2016; 13
Braak, de Vos, Bohl, Del Tredici (bib0025) 2006; 396
Li, Yang, Li, Chen, Liu, Yu (bib0075) 2018; 662
Matsumoto, Wang, Ma, Sung, Matoba, Hwang (bib0150) 2009; 106
Schluter, Fornai, Alessandri, Takamori, Geppert, Jahn, Sudhof (bib0125) 2003; 118
Banerjee, Starkov, Beal, Thomas (bib0050) 2009; 1792
Aubele, Hom, Adler, Galemmo, Bowers, Truong, Pan, Beroza, Neitz, Yao, Lin, Tonn, Zhang, Bova, Ren, Tam, Ruslim, Baker, Diep, Fitzgerald, Hoffman, Motter, Fauss, Tanaka, Dappen, Jagodzinski, Chan, Konradi, Latimer, Zhu, Sham, Anderson, Bergeron, Artis (bib0140) 2013; 8
Chen (10.1016/j.neulet.2019.134640_bib0165) 2015; 286
Oueslati (10.1016/j.neulet.2019.134640_bib0020) 2016; 6
Kim (10.1016/j.neulet.2019.134640_bib0170) 2019; 103
Wu (10.1016/j.neulet.2019.134640_bib0100) 2012; 207
Bourdenx (10.1016/j.neulet.2019.134640_bib0135) 2014; 8
Schluter (10.1016/j.neulet.2019.134640_bib0125) 2003; 118
Aubele (10.1016/j.neulet.2019.134640_bib0140) 2013; 8
Engelender (10.1016/j.neulet.2019.134640_bib0185) 2017; 40
Emborg (10.1016/j.neulet.2019.134640_bib0030) 2017; 58
Canerina-Amaro (10.1016/j.neulet.2019.134640_bib0060) 2019; 13
Riachi (10.1016/j.neulet.2019.134640_bib0120) 1990; 533
Manfredsson (10.1016/j.neulet.2019.134640_bib0175) 2018; 112
Perez-Revuelta (10.1016/j.neulet.2019.134640_bib0145) 2014; 5
Valdinocci (10.1016/j.neulet.2019.134640_bib0195) 2017; 18
Braak (10.1016/j.neulet.2019.134640_bib0025) 2006; 396
Kowall (10.1016/j.neulet.2019.134640_bib0040) 2000; 11
Huang (10.1016/j.neulet.2019.134640_bib0055) 2018; 379
Yu (10.1016/j.neulet.2019.134640_bib0085) 2007; 145
Scudamore (10.1016/j.neulet.2019.134640_bib0130) 2018; 77
El-Agnaf (10.1016/j.neulet.2019.134640_bib0080) 2006; 20
Lee (10.1016/j.neulet.2019.134640_bib0015) 2018; 24
Matsumoto (10.1016/j.neulet.2019.134640_bib0150) 2009; 106
Hinkle (10.1016/j.neulet.2019.134640_bib0105) 2018; 55
Langston (10.1016/j.neulet.2019.134640_bib0045) 1984; 292
Ruffmann (10.1016/j.neulet.2019.134640_bib0115) 2016; 31
Hossain (10.1016/j.neulet.2019.134640_bib0070) 2001; 3
Dong (10.1016/j.neulet.2019.134640_bib0160) 2019; 126
Li (10.1016/j.neulet.2019.134640_bib0075) 2018; 662
Purisai (10.1016/j.neulet.2019.134640_bib0035) 2005; 20
Chen (10.1016/j.neulet.2019.134640_bib0095) 2016; 7
Yue (10.1016/j.neulet.2019.134640_bib0065) 2017; 33
Elgenaidi (10.1016/j.neulet.2019.134640_bib0155) 2019; 198
Nandipati (10.1016/j.neulet.2019.134640_bib0190) 2016; 13
Liu (10.1016/j.neulet.2019.134640_bib0090) 2015; 36
Kozina (10.1016/j.neulet.2019.134640_bib0110) 2014; 340
Kalia (10.1016/j.neulet.2019.134640_bib0005) 2015; 386
Cersosimo (10.1016/j.neulet.2019.134640_bib0010) 2013; 260
Banerjee (10.1016/j.neulet.2019.134640_bib0050) 2009; 1792
Goetze (10.1016/j.neulet.2019.134640_bib0180) 2008; 210
References_xml – volume: 33
  start-page: 17
  year: 2017
  end-page: 27
  ident: bib0065
  article-title: MPTP induces systemic parkinsonism in middle-aged cynomolgus monkeys: clinical evolution and outcomes
  publication-title: Neurosci. Bull.
– volume: 103
  start-page: 627
  year: 2019
  end-page: 641
  ident: bib0170
  article-title: Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson’s disease
  publication-title: Neuron
– volume: 8
  start-page: 1295
  year: 2013
  end-page: 1313
  ident: bib0140
  article-title: Selective and brain-permeable polo-like kinase-2 (Plk-2) inhibitors that reduce alpha-synuclein phosphorylation in rat brain
  publication-title: ChemMedChem
– volume: 18
  year: 2017
  ident: bib0195
  article-title: Potential modes of intercellular alpha-synuclein transmission
  publication-title: Int. J. Mol. Sci.
– volume: 126
  start-page: 178
  year: 2019
  end-page: 186
  ident: bib0160
  article-title: Poloxamer 188 rescues MPTP-induced lysosomal membrane integrity impairment in cellular and mouse models of Parkinson’s disease
  publication-title: Neurochem. Int.
– volume: 6
  start-page: 39
  year: 2016
  end-page: 51
  ident: bib0020
  article-title: Implication of alpha-synuclein phosphorylation at S129 in synucleinopathies: what have we learned in the last decade?
  publication-title: J. Parkinsons Dis.
– volume: 20
  start-page: 419
  year: 2006
  end-page: 425
  ident: bib0080
  article-title: Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson’s disease
  publication-title: FASEB J.
– volume: 379
  start-page: 302
  year: 2018
  end-page: 315
  ident: bib0055
  article-title: Phosphorylated alpha-synuclein accumulations and Lewy body-like pathology distributed in Parkinson’s disease-related brain areas of aged Rhesus monkeys treated with MPTP
  publication-title: Neuroscience
– volume: 118
  start-page: 985
  year: 2003
  end-page: 1002
  ident: bib0125
  article-title: Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
  publication-title: Neuroscience
– volume: 7
  start-page: 8466
  year: 2016
  end-page: 8480
  ident: bib0095
  article-title: Age- and brain region-dependent alpha-synuclein oligomerization is attributed to alterations in intrinsic enzymes regulating alpha-synuclein phosphorylation in aging monkey brains
  publication-title: Oncotarget
– volume: 8
  start-page: 83
  year: 2014
  ident: bib0135
  article-title: Lysosomes and alpha-synuclein form a dangerous duet leading to neuronal cell death
  publication-title: Front. Neuroanat.
– volume: 210
  start-page: 281
  year: 2008
  end-page: 285
  ident: bib0180
  article-title: The role of MPTP in Parkinson’s disease: connecting brain and gut?
  publication-title: Exp. Neurol.
– volume: 386
  start-page: 896
  year: 2015
  end-page: 912
  ident: bib0005
  article-title: Parkinson’s disease
  publication-title: Lancet
– volume: 58
  start-page: 190
  year: 2017
  end-page: 201
  ident: bib0030
  article-title: Nonhuman primate models of neurodegenerative disorders
  publication-title: ILAR J.
– volume: 40
  start-page: 4
  year: 2017
  end-page: 14
  ident: bib0185
  article-title: The threshold theory for Parkinson’s disease
  publication-title: Trends Neurosci.
– volume: 198
  start-page: 68
  year: 2019
  end-page: 89
  ident: bib0155
  article-title: Regulation of the phosphoprotein phosphatase 2A system and its modulation during oxidative stress: a potential therapeutic target
  publication-title: Pharmacol. Ther.
– volume: 13
  start-page: 382
  year: 2019
  ident: bib0060
  article-title: Differential aggregation and phosphorylation of alpha synuclein in membrane compartments associated with parkinson disease
  publication-title: Front. Neurosci.
– volume: 106
  start-page: 14542
  year: 2009
  end-page: 14546
  ident: bib0150
  article-title: Polo-like kinases mediate cell survival in mitochondrial dysfunction
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 11
  start-page: 211
  year: 2000
  end-page: 213
  ident: bib0040
  article-title: MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons
  publication-title: Neuroreport
– volume: 533
  start-page: 6
  year: 1990
  end-page: 14
  ident: bib0120
  article-title: Effects of internal carotid administration of MPTP on rat brain and blood-brain barrier
  publication-title: Brain Res.
– volume: 292
  start-page: 390
  year: 1984
  end-page: 394
  ident: bib0045
  article-title: Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey
  publication-title: Brain Res.
– volume: 31
  start-page: 193
  year: 2016
  end-page: 202
  ident: bib0115
  article-title: Gut feelings about alpha-synuclein in gastrointestinal biopsies: biomarker in the making?
  publication-title: Mov. Disord.
– volume: 5
  start-page: e1209
  year: 2014
  ident: bib0145
  article-title: Metformin lowers Ser-129 phosphorylated alpha-synuclein levels via mTOR-dependent protein phosphatase 2A activation
  publication-title: Cell Death Dis.
– volume: 396
  start-page: 67
  year: 2006
  end-page: 72
  ident: bib0025
  article-title: Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology
  publication-title: Neurosci. Lett.
– volume: 112
  start-page: 106
  year: 2018
  end-page: 118
  ident: bib0175
  article-title: Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology
  publication-title: Neurobiol. Dis.
– volume: 145
  start-page: 539
  year: 2007
  end-page: 555
  ident: bib0085
  article-title: Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody
  publication-title: Neuroscience
– volume: 55
  start-page: 8
  year: 2018
  end-page: 14
  ident: bib0105
  article-title: Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease
  publication-title: Parkinsonism Relat. Disord.
– volume: 24
  start-page: 469
  year: 2018
  end-page: 478
  ident: bib0015
  article-title: Relation of enteric alpha-synuclein to gastrointestinal dysfunction in patients with Parkinson’s disease and in neurologically intact subjects
  publication-title: J. Neurogastroenterol. Motil.
– volume: 207
  start-page: 288
  year: 2012
  end-page: 297
  ident: bib0100
  article-title: Lewy-like aggregation of alpha-synuclein reduces protein phosphatase 2A activity in vitro and in vivo
  publication-title: Neuroscience
– volume: 77
  start-page: 443
  year: 2018
  end-page: 453
  ident: bib0130
  article-title: Increased oxidative stress exacerbates alpha-synuclein aggregation in vivo
  publication-title: J. Neuropathol. Exp. Neurol.
– volume: 662
  start-page: 276
  year: 2018
  end-page: 282
  ident: bib0075
  article-title: Age-dependent elevations of oligomeric and phosphorylated alpha-synuclein synchronously occurs in the brain and gastrointestinal tract of cynomolgus monkeys
  publication-title: Neurosci. Lett.
– volume: 36
  start-page: 2649
  year: 2015
  end-page: 2659
  ident: bib0090
  article-title: Increased oligomerization and phosphorylation of alpha-synuclein are associated with decreased activity of glucocerebrosidase and protein phosphatase 2A in aging monkey brains
  publication-title: Neurobiol. Aging
– volume: 340
  start-page: 198
  year: 2014
  end-page: 207
  ident: bib0110
  article-title: Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism
  publication-title: J. Neurol. Sci.
– volume: 260
  start-page: 1332
  year: 2013
  end-page: 1338
  ident: bib0010
  article-title: Gastrointestinal manifestations in Parkinson’s disease: prevalence and occurrence before motor symptoms
  publication-title: J. Neurol.
– volume: 20
  start-page: 898
  year: 2005
  end-page: 906
  ident: bib0035
  article-title: Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates
  publication-title: Neurobiol. Dis.
– volume: 3
  start-page: 577
  year: 2001
  end-page: 584
  ident: bib0070
  article-title: Limited proteolysis of NACP/alpha-synuclein
  publication-title: J. Alzheimers Dis.
– volume: 1792
  start-page: 651
  year: 2009
  end-page: 663
  ident: bib0050
  article-title: Mitochondrial dysfunction in the limelight of Parkinson’s disease pathogenesis
  publication-title: Biochim. Biophys. Acta
– volume: 286
  start-page: 383
  year: 2015
  end-page: 392
  ident: bib0165
  article-title: Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral alpha-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys
  publication-title: Neuroscience
– volume: 13
  year: 2016
  ident: bib0190
  article-title: Environmental exposures and Parkinson’s disease
  publication-title: Int. J. Environ. Res. Public Health
– volume: 286
  start-page: 383
  year: 2015
  ident: 10.1016/j.neulet.2019.134640_bib0165
  article-title: Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral alpha-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2014.12.003
– volume: 13
  year: 2016
  ident: 10.1016/j.neulet.2019.134640_bib0190
  article-title: Environmental exposures and Parkinson’s disease
  publication-title: Int. J. Environ. Res. Public Health
  doi: 10.3390/ijerph13090881
– volume: 6
  start-page: 39
  year: 2016
  ident: 10.1016/j.neulet.2019.134640_bib0020
  article-title: Implication of alpha-synuclein phosphorylation at S129 in synucleinopathies: what have we learned in the last decade?
  publication-title: J. Parkinsons Dis.
  doi: 10.3233/JPD-160779
– volume: 1792
  start-page: 651
  year: 2009
  ident: 10.1016/j.neulet.2019.134640_bib0050
  article-title: Mitochondrial dysfunction in the limelight of Parkinson’s disease pathogenesis
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbadis.2008.11.007
– volume: 55
  start-page: 8
  year: 2018
  ident: 10.1016/j.neulet.2019.134640_bib0105
  article-title: Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease
  publication-title: Parkinsonism Relat. Disord.
  doi: 10.1016/j.parkreldis.2018.08.010
– volume: 8
  start-page: 83
  year: 2014
  ident: 10.1016/j.neulet.2019.134640_bib0135
  article-title: Lysosomes and alpha-synuclein form a dangerous duet leading to neuronal cell death
  publication-title: Front. Neuroanat.
  doi: 10.3389/fnana.2014.00083
– volume: 20
  start-page: 898
  year: 2005
  ident: 10.1016/j.neulet.2019.134640_bib0035
  article-title: Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2005.05.028
– volume: 396
  start-page: 67
  year: 2006
  ident: 10.1016/j.neulet.2019.134640_bib0025
  article-title: Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2005.11.012
– volume: 210
  start-page: 281
  year: 2008
  ident: 10.1016/j.neulet.2019.134640_bib0180
  article-title: The role of MPTP in Parkinson’s disease: connecting brain and gut?
  publication-title: Exp. Neurol.
  doi: 10.1016/j.expneurol.2008.01.004
– volume: 31
  start-page: 193
  year: 2016
  ident: 10.1016/j.neulet.2019.134640_bib0115
  article-title: Gut feelings about alpha-synuclein in gastrointestinal biopsies: biomarker in the making?
  publication-title: Mov. Disord.
  doi: 10.1002/mds.26480
– volume: 8
  start-page: 1295
  year: 2013
  ident: 10.1016/j.neulet.2019.134640_bib0140
  article-title: Selective and brain-permeable polo-like kinase-2 (Plk-2) inhibitors that reduce alpha-synuclein phosphorylation in rat brain
  publication-title: ChemMedChem
  doi: 10.1002/cmdc.201300166
– volume: 126
  start-page: 178
  year: 2019
  ident: 10.1016/j.neulet.2019.134640_bib0160
  article-title: Poloxamer 188 rescues MPTP-induced lysosomal membrane integrity impairment in cellular and mouse models of Parkinson’s disease
  publication-title: Neurochem. Int.
  doi: 10.1016/j.neuint.2019.03.013
– volume: 112
  start-page: 106
  year: 2018
  ident: 10.1016/j.neulet.2019.134640_bib0175
  article-title: Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2018.01.008
– volume: 24
  start-page: 469
  year: 2018
  ident: 10.1016/j.neulet.2019.134640_bib0015
  article-title: Relation of enteric alpha-synuclein to gastrointestinal dysfunction in patients with Parkinson’s disease and in neurologically intact subjects
  publication-title: J. Neurogastroenterol. Motil.
  doi: 10.5056/jnm17141
– volume: 106
  start-page: 14542
  year: 2009
  ident: 10.1016/j.neulet.2019.134640_bib0150
  article-title: Polo-like kinases mediate cell survival in mitochondrial dysfunction
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0904229106
– volume: 118
  start-page: 985
  year: 2003
  ident: 10.1016/j.neulet.2019.134640_bib0125
  article-title: Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
  publication-title: Neuroscience
  doi: 10.1016/S0306-4522(03)00036-8
– volume: 40
  start-page: 4
  year: 2017
  ident: 10.1016/j.neulet.2019.134640_bib0185
  article-title: The threshold theory for Parkinson’s disease
  publication-title: Trends Neurosci.
  doi: 10.1016/j.tins.2016.10.008
– volume: 292
  start-page: 390
  year: 1984
  ident: 10.1016/j.neulet.2019.134640_bib0045
  article-title: Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey
  publication-title: Brain Res.
  doi: 10.1016/0006-8993(84)90777-7
– volume: 662
  start-page: 276
  year: 2018
  ident: 10.1016/j.neulet.2019.134640_bib0075
  article-title: Age-dependent elevations of oligomeric and phosphorylated alpha-synuclein synchronously occurs in the brain and gastrointestinal tract of cynomolgus monkeys
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2017.10.047
– volume: 20
  start-page: 419
  year: 2006
  ident: 10.1016/j.neulet.2019.134640_bib0080
  article-title: Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson’s disease
  publication-title: FASEB J.
  doi: 10.1096/fj.03-1449com
– volume: 379
  start-page: 302
  year: 2018
  ident: 10.1016/j.neulet.2019.134640_bib0055
  article-title: Phosphorylated alpha-synuclein accumulations and Lewy body-like pathology distributed in Parkinson’s disease-related brain areas of aged Rhesus monkeys treated with MPTP
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2018.03.026
– volume: 207
  start-page: 288
  year: 2012
  ident: 10.1016/j.neulet.2019.134640_bib0100
  article-title: Lewy-like aggregation of alpha-synuclein reduces protein phosphatase 2A activity in vitro and in vivo
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2012.01.028
– volume: 198
  start-page: 68
  year: 2019
  ident: 10.1016/j.neulet.2019.134640_bib0155
  article-title: Regulation of the phosphoprotein phosphatase 2A system and its modulation during oxidative stress: a potential therapeutic target
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2019.02.011
– volume: 77
  start-page: 443
  year: 2018
  ident: 10.1016/j.neulet.2019.134640_bib0130
  article-title: Increased oxidative stress exacerbates alpha-synuclein aggregation in vivo
  publication-title: J. Neuropathol. Exp. Neurol.
  doi: 10.1093/jnen/nly024
– volume: 533
  start-page: 6
  year: 1990
  ident: 10.1016/j.neulet.2019.134640_bib0120
  article-title: Effects of internal carotid administration of MPTP on rat brain and blood-brain barrier
  publication-title: Brain Res.
  doi: 10.1016/0006-8993(90)91788-I
– volume: 103
  start-page: 627
  year: 2019
  ident: 10.1016/j.neulet.2019.134640_bib0170
  article-title: Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson’s disease
  publication-title: Neuron
  doi: 10.1016/j.neuron.2019.05.035
– volume: 260
  start-page: 1332
  year: 2013
  ident: 10.1016/j.neulet.2019.134640_bib0010
  article-title: Gastrointestinal manifestations in Parkinson’s disease: prevalence and occurrence before motor symptoms
  publication-title: J. Neurol.
  doi: 10.1007/s00415-012-6801-2
– volume: 58
  start-page: 190
  year: 2017
  ident: 10.1016/j.neulet.2019.134640_bib0030
  article-title: Nonhuman primate models of neurodegenerative disorders
  publication-title: ILAR J.
  doi: 10.1093/ilar/ilx021
– volume: 36
  start-page: 2649
  year: 2015
  ident: 10.1016/j.neulet.2019.134640_bib0090
  article-title: Increased oligomerization and phosphorylation of alpha-synuclein are associated with decreased activity of glucocerebrosidase and protein phosphatase 2A in aging monkey brains
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2015.06.004
– volume: 386
  start-page: 896
  year: 2015
  ident: 10.1016/j.neulet.2019.134640_bib0005
  article-title: Parkinson’s disease
  publication-title: Lancet
  doi: 10.1016/S0140-6736(14)61393-3
– volume: 5
  start-page: e1209
  year: 2014
  ident: 10.1016/j.neulet.2019.134640_bib0145
  article-title: Metformin lowers Ser-129 phosphorylated alpha-synuclein levels via mTOR-dependent protein phosphatase 2A activation
  publication-title: Cell Death Dis.
  doi: 10.1038/cddis.2014.175
– volume: 145
  start-page: 539
  year: 2007
  ident: 10.1016/j.neulet.2019.134640_bib0085
  article-title: Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2006.12.028
– volume: 33
  start-page: 17
  year: 2017
  ident: 10.1016/j.neulet.2019.134640_bib0065
  article-title: MPTP induces systemic parkinsonism in middle-aged cynomolgus monkeys: clinical evolution and outcomes
  publication-title: Neurosci. Bull.
  doi: 10.1007/s12264-016-0069-y
– volume: 3
  start-page: 577
  year: 2001
  ident: 10.1016/j.neulet.2019.134640_bib0070
  article-title: Limited proteolysis of NACP/alpha-synuclein
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-2001-3608
– volume: 13
  start-page: 382
  year: 2019
  ident: 10.1016/j.neulet.2019.134640_bib0060
  article-title: Differential aggregation and phosphorylation of alpha synuclein in membrane compartments associated with parkinson disease
  publication-title: Front. Neurosci.
  doi: 10.3389/fnins.2019.00382
– volume: 11
  start-page: 211
  year: 2000
  ident: 10.1016/j.neulet.2019.134640_bib0040
  article-title: MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons
  publication-title: Neuroreport
  doi: 10.1097/00001756-200001170-00041
– volume: 7
  start-page: 8466
  year: 2016
  ident: 10.1016/j.neulet.2019.134640_bib0095
  article-title: Age- and brain region-dependent alpha-synuclein oligomerization is attributed to alterations in intrinsic enzymes regulating alpha-synuclein phosphorylation in aging monkey brains
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.6445
– volume: 18
  year: 2017
  ident: 10.1016/j.neulet.2019.134640_bib0195
  article-title: Potential modes of intercellular alpha-synuclein transmission
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms18020469
– volume: 340
  start-page: 198
  year: 2014
  ident: 10.1016/j.neulet.2019.134640_bib0110
  article-title: Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism
  publication-title: J. Neurol. Sci.
  doi: 10.1016/j.jns.2014.03.028
SSID ssj0005154
Score 2.407491
Snippet •α-Syn oligomerization occurs in parallel in the brain and colon of MPTP-treated monkeys.•α-Syn oligomerization correlates with its phosphorylation in...
Dopaminergic (DAergic) degeneration and abnormal α-synuclein (α-syn) expression, phosphorylation and aggregation are observed in both the nigrostriatal system...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 134640
SubjectTerms alpha-Synuclein - metabolism
Animals
Brain - metabolism
Brain - pathology
Colon
Dopaminergic neurons
Dopaminergic Neurons - pathology
Enteric Nervous System - metabolism
Enteric Nervous System - pathology
Macaca fascicularis
Male
Nerve Degeneration - metabolism
Nerve Degeneration - pathology
Parkinsonian Disorders - metabolism
Parkinsonian Disorders - pathology
Parkinson’s disease
Striatum
Substantia nigra
α-synuclein
Title Alpha-synuclein oligomerization and dopaminergic degeneration occur synchronously in the brain and colon of MPTP-intoxicated parkinsonian monkeys
URI https://dx.doi.org/10.1016/j.neulet.2019.134640
https://www.ncbi.nlm.nih.gov/pubmed/31759083
https://www.proquest.com/docview/2317587544
Volume 716
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swEBalg7GXsbX7kXUtGoy9qbFiy7UeQ2nJNlIKa6FvQjopxSOVQ5NA89L_of_x7mS7bLBR2Ksl2UJ3vvuku_vE2GcVqsxVKhMAWokCRlZY8KXQUNhMQ8ikpULh6Vk5uSy-XamrLXbc18JQWmVn-1ubnqx192TYreZwUdfDHxTUo3u9EYKQH6SC36I4Ii0_vP8tzUOqlkKKIgDYuy-fSzleMaxxdSjBSx_KvCjpCOTv7ulf8DO5odNX7GWHH_m4neJrthXiDtsdR9w732z4F54yOtNR-Q57Pu0C57vsYUw1tWK5icRfXEfezOvrhqI1bRkmt9Fzjxvom1QMWAP34ToxUqfWBmB9y3E0EJdus17ONxxfguCRO7pjIg0n_mvsOuPT84tzUcdVc5cK7DxfWDqRR2SPushR79FwLN-wy9OTi-OJ6G5jEIBObiXAIVIKHqWJu55cOlUA0ddLa3HZfI6WQivwtqwUKKcgz8EHG1wFswBZsCp_y7ZjE8N7xpUM5ayypdajgHDMukLPvNaB6ABl7uyA5b0QDHRU5XRjxtz0OWk_TSs6Q6IzregGTDyOWrRUHU_0P-rla_5QOYPe5ImRn3p1MPg3UojFxoCLb0YExyoiFRywd62ePM6FmjQi3g___d099mJE2_1MCll9ZNur23XYR0y0cgdJ6Q_Ys_HX75OzXyuED6E
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBddB9textbuI_vUYOxNjRVbnvUYykq2NaWwFPompJNSXFI5NAksL_sf9h_vTrbLBhuFvcaSY3Snu590d79j7L0KVeYqlQkArUQBIyss-FJoKGymIWTSUqHw9KScnBVfztX5Djvsa2EorbKz_a1NT9a6-2XYreZwWdfDbxTUo77eCEHID1Z32N0Cty-1MTj48Vueh1QthxSFAHB4Xz-Xkrxi2ODyUIaXPpB5UdIdyN_907_wZ_JDR4_Yww5A8nH7jY_ZToh7bH8c8fB8teUfeErpTHfle-zetIuc77OfYyqqFattJALjOvJmUV80FK5p6zC5jZ57PEFfpWrAGrgPF4mSOj1tADbXHGcDkek2m9Viy_EliB65oyYTaToRYOPQOZ-ezk5FHdfN91Rh5_nS0pU8QntURo6Kj5Zj9YSdHX2aHU5E145BAHq5tQCHUCl4FCcee3LpVAHEXy-txWXzOZoKrcDbslKgnII8Bx9scBXMA2TBqvwp241NDM8ZVzKU88qWWo8C4jHrCj33WgfiA5S5swOW90Iw0HGVU8uMhemT0i5NKzpDojOt6AZM3Mxatlwdt4z_2MvX_KFzBt3JLTPf9epgcDtSjMXGgItvRoTHKmIVHLBnrZ7cfAs90gh5X_z3_75l9yez6bE5_nzy9SV7MKKzfyaFrF6x3fX1JrxGgLR2b9IG-AU7nhEv
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alpha-synuclein+oligomerization+and+dopaminergic+degeneration+occur+synchronously+in+the+brain+and+colon+of+MPTP-intoxicated+parkinsonian+monkeys&rft.jtitle=Neuroscience+letters&rft.au=Li%2C+Xuran&rft.au=Yang%2C+Weiwei&rft.au=Li%2C+Xin&rft.au=Chen%2C+Min&rft.date=2020-01-18&rft.issn=1872-7972&rft.eissn=1872-7972&rft.volume=716&rft.spage=134640&rft_id=info:doi/10.1016%2Fj.neulet.2019.134640&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-3940&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-3940&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-3940&client=summon